Agenus Reports Q3 Profit and First Marketing Authorization for BOT+BAL in Armenia

Filing content

Agenus reported its third consecutive quarter of positive operating income for Q3 2026. The company also received the first global marketing authorization for its BOT+BAL combination in Armenia and is preparing for the Phase 3 ROBBIN trial.